摩根大通-与两位肿瘤学家交流的要点:治疗选择和MRD仍有较大发展空间,但对分子进展持怀疑态度-Takeaways from Our Conversations with Two Oncologists:More Room to Run for Therapy Selection and MRD;but Skepticism of-20261019【13页】

发表回复

后才能评论